Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
41.90
-0.03 (-0.07%)
Apr 30, 2025, 3:00 PM CST
SHA:600976 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2015 - 2019 |
Market Capitalization | 6,427 | 6,394 | 9,916 | 7,551 | 11,989 | 3,895 | Upgrade
|
Market Cap Growth | -21.32% | -35.52% | 31.31% | -37.01% | 207.81% | 42.88% | Upgrade
|
Enterprise Value | 5,392 | 5,531 | 9,131 | 6,672 | 11,258 | 3,392 | Upgrade
|
Last Close Price | 41.90 | 40.80 | 62.52 | 46.90 | 73.07 | 23.31 | Upgrade
|
PE Ratio | 17.04 | 17.65 | 19.02 | 18.50 | 39.27 | 26.35 | Upgrade
|
Forward PE | - | 15.25 | 15.25 | 15.25 | 15.25 | 15.25 | Upgrade
|
PS Ratio | 1.88 | 1.82 | 2.35 | 2.07 | 3.63 | 1.59 | Upgrade
|
PB Ratio | 2.51 | 2.61 | 4.39 | 4.05 | 8.06 | 2.94 | Upgrade
|
P/TBV Ratio | 2.55 | 2.66 | 4.47 | 4.13 | 8.28 | 3.01 | Upgrade
|
P/FCF Ratio | 46.85 | 56.10 | 48.63 | 51.06 | 62.52 | 48.71 | Upgrade
|
P/OCF Ratio | 24.63 | 27.29 | 36.95 | 34.98 | 48.36 | 31.03 | Upgrade
|
EV/Sales Ratio | 1.57 | 1.58 | 2.17 | 1.83 | 3.41 | 1.38 | Upgrade
|
EV/EBITDA Ratio | 16.80 | 23.41 | 26.45 | 22.62 | 47.72 | 45.60 | Upgrade
|
EV/EBIT Ratio | 19.28 | 27.46 | 29.16 | 25.39 | 54.27 | 63.18 | Upgrade
|
EV/FCF Ratio | 39.30 | 48.53 | 44.78 | 45.11 | 58.71 | 42.42 | Upgrade
|
Debt / Equity Ratio | 0.06 | 0.07 | 0.05 | 0.03 | 0.05 | 0.02 | Upgrade
|
Debt / EBITDA Ratio | 0.54 | 0.73 | 0.33 | 0.18 | 0.30 | 0.27 | Upgrade
|
Debt / FCF Ratio | 1.12 | 1.54 | 0.56 | 0.36 | 0.37 | 0.25 | Upgrade
|
Asset Turnover | 0.80 | 0.83 | 1.11 | 1.16 | 1.25 | 1.13 | Upgrade
|
Inventory Turnover | 4.31 | 4.55 | 5.60 | 7.06 | 8.34 | 8.03 | Upgrade
|
Quick Ratio | 1.39 | 1.20 | 1.18 | 1.16 | 1.17 | 1.10 | Upgrade
|
Current Ratio | 1.65 | 1.49 | 1.49 | 1.50 | 1.41 | 1.42 | Upgrade
|
Return on Equity (ROE) | 15.40% | 15.63% | 25.39% | 24.22% | 21.77% | 11.75% | Upgrade
|
Return on Assets (ROA) | 3.50% | 2.98% | 5.14% | 5.22% | 4.92% | 1.54% | Upgrade
|
Return on Capital (ROIC) | 5.80% | 5.04% | 9.12% | 9.45% | 8.93% | 2.63% | Upgrade
|
Return on Capital Employed (ROCE) | 9.10% | 8.00% | 13.50% | 13.80% | 13.50% | 4.00% | Upgrade
|
Earnings Yield | 5.80% | 5.67% | 5.26% | 5.40% | 2.55% | 3.79% | Upgrade
|
FCF Yield | 2.13% | 1.78% | 2.06% | 1.96% | 1.60% | 2.05% | Upgrade
|
Dividend Yield | 2.15% | - | 1.92% | 2.13% | 1.10% | 1.57% | Upgrade
|
Payout Ratio | 50.35% | 51.83% | 29.95% | 30.39% | 19.20% | 21.07% | Upgrade
|
Buyback Yield / Dilution | 0.83% | 0.49% | -0.43% | -0.26% | 1.35% | -0.96% | Upgrade
|
Total Shareholder Return | 2.98% | 0.49% | 1.49% | 1.87% | 2.45% | 0.61% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.